LWAC insider transactions
LightWave Acquisition Corp. (LWAC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
LWAC insiders
Everyone who has filed a Form 3, 4, 5 or 144 at LightWave Acquisition Corp., latest first. Follow anyone to get their next filing.
- Allen Charles DickasonDirector, since June 2025
- LightWave Founders LLC10% owner, since June 2025+$6.06M
- William Whithorne Bunker JRCFO & VC of the Board, Director, since June 2025
- Charlotte BlechmanDirector, since June 2025
- Robert HochbergDirector, since June 2025
- Christopher B EhrlichDirector
- Elizabeth BhattDirector
- John W SmitherDirector, since August 2020
- Jonathan D RootDirector, 10% owner, since August 2021
- Laurence LaskyDirector, since August 2021
- Brian M. Gallagher Jr.Director, 10% owner, since August 2021
- Column Group II GP, LP10% owner, since August 2021
- Sr One Capital Management, LLC10% owner, since August 2021
- Presidio Management Group X LLC10% owner, since August 2021
- LLP Abingworth10% owner, since August 2021
- Locust Walk Sponsor, LLC10% owner
- Premal PatelOfficer, since August 2021
- Alana B. McNultyOfficer, since August 2021
- Michael ByrnesOfficer, since August 2021
- Stephen T WorlandOfficer, Director, since August 2021
Recent Form 3, 4, and 5 filings for LWAC
- SEC Form 3 filed by new insider Dickason Allen Charles3 - LightWave Acquisition Corp. (0002061379) (Issuer)
- Large owner Lightwave Founders Llc bought $6,062,500 worth of Class A ordinary shares (606,250 units at $10.00) (SEC Form 4)4 - LightWave Acquisition Corp. (0002061379) (Issuer)
- SEC Form 3 filed by new insider Lightwave Founders Llc3 - LightWave Acquisition Corp. (0002061379) (Issuer)
- SEC Form 3 filed by new insider Bunker William Whithorne Jr3 - LightWave Acquisition Corp. (0002061379) (Issuer)
- SEC Form 3 filed by new insider Blechman Charlotte3 - LightWave Acquisition Corp. (0002061379) (Issuer)
- SEC Form 3 filed by new insider Hochberg Robert3 - LightWave Acquisition Corp. (0002061379) (Issuer)
- SEC Form 4 filed by Ehrlich Christopher B4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4 filed by Bhatt Elizabeth4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4 filed by Smither John W4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4 filed by Root Jonathan D4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4 filed by Lasky Laurence4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4 filed by Gallagher Brian M. Jr.4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3: New insider Column Group Ii Gp, Lp claimed ownership of 4,309,329 units of Common Stock3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3: New insider Sr One Capital Management, Llc claimed ownership of 6,822,114 units of Common Stock3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3: New insider Presidio Management Group X Llc claimed ownership of 4,822,114 units of Common Stock3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4: Root Jonathan D was granted 4,822,114 units of Common Stock4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4: Ehrlich Christopher B converted options into 143,202 units of Common Stock4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3 filed by new insider Root Jonathan D3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4: Bhatt Elizabeth converted options into 9,047 units of Class A Common Stock4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4: Gallagher Brian M. Jr. was granted 4,822,114 units of Common Stock4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3 filed by new insider Gallagher Brian M. Jr.3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3 filed by new insider Lasky Laurence3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3: New insider Abingworth Llp claimed ownership of 4,822,114 units of Common Stock3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4: Locust Walk Sponsor, Llc converted options into 3,511,250 units of Common Stock, increasing direct ownership by 644% to 4,056,250 units4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4: Smither John W was granted 24,142 units of Common Stock4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3 filed by new insider Smither John W3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4 filed by Patel Premal4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3 filed by new insider Patel Premal3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4: Mcnulty Alana B. was granted 48,768 units of Common Stock4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3 filed by new insider Mcnulty Alana B.3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4 filed by Byrnes Michael4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 4: Worland Stephen T was granted 755,480 units of Common Stock, increasing direct ownership by 34% to 755,480 units4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3 filed by new insider Byrnes Michael3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
- SEC Form 3 filed by new insider Worland Stephen T3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)